Cancer Care Ontario | Action Cancer Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

9 Results

Guidelines and Advice

Ibritumomab Tiuxetan in Lymphoma

Status: Archived
ID: 6-17

Nov 2013

Guidelines and Advice

Iodine-131 Tositumomab in Lymphoma

Status: Archived
ID: 6-19

Jan 2007

Guidelines and Advice

Recommendations for the Delivery of Psychosocial Oncology Services in Ontario

Status: Current

Dec 1969

Guidelines and Advice

Position Statements for Nursing Practice in Cancer Care

Status: Current
Version: 2

Dec 1969

Guidelines and Advice

Follow-Up Model of Care for Cancer Survivors: Recommendations for the Delivery of Follow-up Care for Cancer Survivors in Ontario

Status: Current
ID: N/A
Version: N/A

Mar 2019

Guidelines and Advice

Oncology Caregiver Support Framework

Status: Current
ID: N/A
Version: N/A

Oct 2019

Guidelines and Advice

Pandemic Planning Clinical Guideline for Patients with Cancer

Status: Current
Version: 2

Dec 1969

Guidelines and Advice

Organizational Guidance for the Care of Patients with Central Nervous System Tumours in Ontario: Consensus Recommendations

Status: Current
ID: GL 9-11

Oct 2024

Guidelines and Advice

An Endorsement of the ASTRO/ESTRO 2023 Guideline for the Treatment of Patients with Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer

Status: Current
ID: GL END 7-24

Updated

Nov 2024